Novo Nordisk overtakes SAP as Europe’s most valuable company
Novo Nordisk A/S reclaimed its position as Europe’s most valuable public company, overtaking software developer SAP SE.
Shares in the Danish drugmaker climbed as much as 2.3% on Friday after Novo said it plans to advance its experimental weight management treatment amycretin into late-stage development following feedback from regulatory authorities.
Novo’s market capitalization stood at $365 billion as of 10:20 a.m. in Copenhagen. That compares with $364.3 billion for SAP, according to data compiled by Bloomberg.
Заголовки